Direxion Launches four new 2X Leveraged ETFs

Direxion has announced the launch of four new leveraged exchange-traded funds (ETFs) that provide 2X Bull and Bear exposure to cyber Security and pharmaceuticals.…

Sign up for our weekly Newsletter and receive the latest ETF and ETC news. Click here to register for your free cop

The Direxion Daily Cyber Security Bull and Bear 2X Shares (Tickers: HAKK/HAKD) seek to achieve 200% and 200% of the inverse, respectively, of the daily performance of the ISE Cyber Security^™ Index. The Direxion Daily Pharmaceutical & Medical Bull and Bear 2X Shares (Tickers: PILL/PILS) seek to achieve 200% and 200% of the inverse, respectively, of the daily performance of the Dynamic Pharmaceutical Intellidex Index.

“Traders and investors continue to express keen interest in the cyber security and pharmaceutical sectors,” said Sylvia Jablonski, Managing Director at Direxion. “Our new leveraged ETFs enable traders to benefit from exposure to these industries, regardless of market conditions and sector performance, in a flexible way.”

Like all leveraged ETFs, these Direxion products are intended only for investors with an in-depth understanding of the risks associated with seeking leveraged investment results, and who plan to actively monitor and manage their positions. There is no guarantee that the Funds will meet their objectives. 

Source: ETFWorld.com

WMCR
Wilshire Micro-Cap ETF (based on the Wilshire US Micro-Cap Index)